Help safeguard yourself against lower respiratory tract disease caused by RSV
Ask your doctor if mRESVIA is right for you.
mRESVIA® is a vaccine used to help protect against lower respiratory tract disease caused by RSV. It is for people 60 years of age and older, and people 18 through 59 years of age who are at increased risk for RSV.


Am I eligible?
mRESVIA can be given to people aged 60 years and older and to those aged 18–59 years who are at increased risk for RSV due to certain medical conditions.
Depending on where you live within Canada, you may be able to receive an RSV vaccine directly from your local pharmacy; however, in some provinces, you may need to receive a prescription from your doctor first.
Use the dropdown menu below to find out how to access an RSV vaccine in your area – as well as whether it is covered through public funding.
Is the RSV vaccine covered in my province?
To view the eligibility criteria for your area, please select from the list of provinces and territories.
Important: eligibility criteria may change periodically. Talk to your healthcare professional for the latest information.
RSV vaccine not publicly funded in your province/territory?
Many private health insurance providers cover prescription-based (Schedule 1) vaccines as part of their health policies – however plans can vary by employer.
Contact your health insurance provider to see if mRESVIA is covered on your plan.
* Made in Canada with domestic and imported parts.
We’re here to help
Get in touch with questions or for any information you may need.
Call us
1-866-MODERNA (1-866-663-3762)
8:00 AM – 8:00 PM, ET
Monday – Friday (closed holidays)
Important information
mRESVIA® is a vaccine used to help protect against lower respiratory tract disease caused by RSV. It is for people 60 years of age and older, and people 18 through 59 years of age who are at increased risk for RSV.
mRESVIA is contraindicated for use in children younger than 2 years of age due to an increased risk of RSV enhanced respiratory disease. The risk of RSV-enhanced respiratory disease is not applicable to adults.
As with any vaccine, mRESVIA may not fully protect all people who receive it.
The most common side effects of mRESVIA include pain at the injection site, fatigue, chills, headache, swelling of lymph nodes, muscle pain, joint pain, redness and swelling at the injection site, fever, nausea, and vomiting. Allergic reactions may also occur.
Vaccination may not be suitable for everyone. Ask your healthcare professional if mRESVIA is right for you. Full product information is available at mresvia.ca/pmi, or by calling 1-866-MODERNA (1-866-663-3762). To report an adverse event, please call 1-866-MODERNA (1-866-663-3762).